{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:44:57Z","timestamp":1777927497215,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T00:00:00Z","timestamp":1245715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T00:00:00Z","timestamp":1245715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The expression of additional genes, other than oestrogen receptor (ER), may be important to the hormone-responsive phenotype of breast cancer. Microarray analyses have revealed that forkhead box A1 (FOXA1) and GATA binding protein 3 (GATA-3) are expressed in close association with ER\u03b1, both encoding for transcription factors with a potential involvement in the ER\u03b1-mediated action in breast cancer. The purpose of this study was to explore if the expression of FOXA1 and GATA-3 may provide an opportunity to stratify subsets of patients that could have better outcome, among the ER\u03b1-negative\/poor prognosis breast cancer group.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We evaluate FOXA1 and GATA-3 expression in 249 breast carcinomas by immunohistochemistry, associating it with breast cancer molecular markers, clinicopathological features and patient's survival. The clinicopathological features and immunohistochemical markers of the tumours were compared using the chi-square test and ANOVA. Disease-free survival was analysed through Kaplan\u2013Meier survival curves and Cox regression.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>FOXA1 expression was demonstrated in 42% of invasive carcinomas, while GATA-3 was detected in 48% of the cases. FOXA1 expression was inversely associated with tumour size, Nottingham Prognostic Index, histological grade, lymph vascular invasion, lymph node stage and human epidermal growth factor receptor-2 (HER-2) overexpression, while GATA-3 expression showed inverse association with histological grade and HER-2. Both FOXA1 and GATA-3 were directly associated with ER\u03b1 and progesterone receptor. Among FOXA1-positive tumours, 83.1% are comprised in the luminal A subtype, similar to GATA-3 where 87.7% of positive tumours were classified within this molecular subtype. In the subset of ER\u03b1-negative patients, those who were FOXA1-negative had a 3.61-fold increased risk of breast cancer recurrence when compared with the FOXA1-positive.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>FOXA1 was a significant predictor of good outcome in breast cancer, whereas GATA-3 was an important luminal marker. The expression of FOXA1 may be used for risk stratification among ER\u03b1-negative patients.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr2327","type":"journal-article","created":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T18:14:37Z","timestamp":1245780877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours"],"prefix":"10.1186","volume":"11","author":[{"given":"Andr\u00e9","family":"Albergaria","sequence":"first","affiliation":[]},{"given":"Joana","family":"Paredes","sequence":"additional","affiliation":[]},{"given":"B\u00e1rbara","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Milanezi","sequence":"additional","affiliation":[]},{"given":"V\u00edtor","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Daniella","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Nair","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Eric W","family":"Lam","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Lunet","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,6,23]]},"reference":[{"key":"2291_CR1","first-page":"202","volume":"12","author":"WA Knight 3rd","year":"1980","unstructured":"Knight WA, Osborne CK, Yochmowitz MG, McGuire WL: Steroid hormone receptors in the management of human breast cancer. Ann Clin Res. 1980, 12: 202-207.","journal-title":"Ann Clin Res"},{"key":"2291_CR2","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/ijc.22234","volume":"119","author":"J Schneider","year":"2006","unstructured":"Schneider J, Ruschhaupt M, Buness A, Asslaber M, Regitnig P, Zatloukal K, Schippinger W, Ploner F, Poustka A, Sultmann H: Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer. Int J Cancer. 2006, 119: 2974-2979. 10.1002\/ijc.22234.","journal-title":"Int J Cancer"},{"key":"2291_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/10408368809106860","volume":"26","author":"VC Jordan","year":"1988","unstructured":"Jordan VC, Wolf MF, Mirecki DM, Whitford DA, Welshons WV: Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast. Crit Rev Clin Lab Sci. 1988, 26: 97-152. 10.3109\/10408368809106860.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2291_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, Rijn van de M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, L\u00f8nning PE, B\u00f8rresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038\/35021093.","journal-title":"Nature"},{"key":"2291_CR5","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn van de M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein L\u00f8nning P, B\u00f8rresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2291_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ van de Vijver","year":"2002","unstructured":"Vijver van de MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, Velde van der T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002, 347: 1999-2009. 10.1056\/NEJMoa021967.","journal-title":"N Engl J Med"},{"key":"2291_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003, 33: 49-54. 10.1038\/ng1060.","journal-title":"Nat Genet"},{"key":"2291_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.2407","volume":"216","author":"B Weigelt","year":"2008","unstructured":"Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, de Jong D, Vijver Van de MJ, Van't Veer LJ, Peterse JL: Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008, 216: 141-150. 10.1002\/path.2407.","journal-title":"J Pathol"},{"key":"2291_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S","volume":"84","author":"RV Hoch","year":"1999","unstructured":"Hoch RV, Thompson DA, Baker RJ, Weigel RJ: GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer. 1999, 84: 122-128. 10.1002\/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S.","journal-title":"Int J Cancer"},{"key":"2291_CR10","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-07-0122","volume":"13","author":"S Badve","year":"2007","unstructured":"Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H: FOXA1 expression in breast cancer \u2013 correlation with luminal subtype A and survival. Clin Cancer Res. 2007, 13: 4415-4421. 10.1158\/1078-0432.CCR-07-0122.","journal-title":"Clin Cancer Res"},{"key":"2291_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2004.02.021","volume":"219","author":"M Lacroix","year":"2004","unstructured":"Lacroix M, Leclercq G: About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol Cell Endocrinol. 2004, 219: 1-7. 10.1016\/j.mce.2004.02.021.","journal-title":"Mol Cell Endocrinol"},{"key":"2291_CR12","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1200\/JCO.2005.03.2755","volume":"24","author":"DS Oh","year":"2006","unstructured":"Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM: Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol. 2006, 24: 1656-1664. 10.1200\/JCO.2005.03.2755.","journal-title":"J Clin Oncol"},{"key":"2291_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1210\/me.2005-0334","volume":"20","author":"JS Carroll","year":"2006","unstructured":"Carroll JS, Brown M: Estrogen receptor target gene: an evolving concept. Mol Endocrinol. 2006, 20: 1707-1714. 10.1210\/me.2005-0334.","journal-title":"Mol Endocrinol"},{"key":"2291_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2005.05.008","volume":"122","author":"JS Carroll","year":"2005","unstructured":"Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M: Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell. 2005, 122: 33-43. 10.1016\/j.cell.2005.05.008.","journal-title":"Cell"},{"key":"2291_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/dbio.2002.0780","volume":"250","author":"P Carlsson","year":"2002","unstructured":"Carlsson P, Mahlapuu M: Forkhead transcription factors: key players in development and metabolism. Dev Biol. 2002, 250: 1-23. 10.1006\/dbio.2002.0780.","journal-title":"Dev Biol"},{"key":"2291_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1043-2760(00)00271-X","volume":"11","author":"KH Kaestner","year":"2000","unstructured":"Kaestner KH: The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab. 2000, 11: 281-285. 10.1016\/S1043-2760(00)00271-X.","journal-title":"Trends Endocrinol Metab"},{"key":"2291_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2003.08.148","volume":"310","author":"Y Tomaru","year":"2003","unstructured":"Tomaru Y, Kondo S, Suzuki M, Hayashizaki Y: A comprehensive search for HNF-3\u03b1-regulated genes in mouse hepatoma cells by 60K cDNA microarray and chromatin immunoprecipitation\/PCR analysis. Biochem Biophys Res Commun. 2003, 310: 667-674. 10.1016\/j.bbrc.2003.08.148.","journal-title":"Biochem Biophys Res Commun"},{"key":"2291_CR18","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/pnas.0505575102","volume":"102","author":"J Laganiere","year":"2005","unstructured":"Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V: From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci USA. 2005, 102: 11651-11656. 10.1073\/pnas.0505575102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2291_CR19","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1038\/sj.onc.1208991","volume":"24","author":"YN Liu","year":"2005","unstructured":"Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH: Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene. 2005, 24: 8277-8290. 10.1038\/sj.onc.1208991.","journal-title":"Oncogene"},{"key":"2291_CR20","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.onc.1209170","volume":"25","author":"EA Williamson","year":"2006","unstructured":"Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP: BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene. 2006, 25: 1391-1399. 10.1038\/sj.onc.1209170.","journal-title":"Oncogene"},{"key":"2291_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ncb1530","volume":"9","author":"ML Asselin-Labat","year":"2007","unstructured":"Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, Wees van der J, Lindeman GJ, Visvader JE: Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007, 9: 201-209. 10.1038\/ncb1530.","journal-title":"Nat Cell Biol"},{"key":"2291_CR22","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","volume":"127","author":"H Kouros-Mehr","year":"2006","unstructured":"Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z: GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006, 127: 1041-1055. 10.1016\/j.cell.2006.09.048.","journal-title":"Cell"},{"key":"2291_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/445724a","volume":"445","author":"Q Tong","year":"2007","unstructured":"Tong Q, Hotamisligil GS: Developmental biology: cell fate in the mammary gland. Nature. 2007, 445: 724-726. 10.1038\/445724a.","journal-title":"Nature"},{"key":"2291_CR24","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.1158\/0008-5472.CAN-05-2495","volume":"65","author":"R Mehra","year":"2005","unstructured":"Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG: Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 2005, 65: 11259-11264. 10.1158\/0008-5472.CAN-05-2495.","journal-title":"Cancer Res"},{"key":"2291_CR25","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/hmg\/9.20.2981","volume":"9","author":"F Bertucci","year":"2000","unstructured":"Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Ad\u00e9la\u00efde J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B, Birnbaum D, Nguyen C: Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet. 2000, 9: 2981-2991. 10.1093\/hmg\/9.20.2981.","journal-title":"Hum Mol Genet"},{"key":"2291_CR26","first-page":"5979","volume":"61","author":"S Gruvberger","year":"2001","unstructured":"Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001, 61: 5979-5984.","journal-title":"Cancer Res"},{"key":"2291_CR27","doi-asserted-by":"publisher","first-page":"11462","DOI":"10.1073\/pnas.201162998","volume":"98","author":"M West","year":"2001","unstructured":"West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA, Marks JR, Nevins JR: Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA. 2001, 98: 11462-11467. 10.1073\/pnas.201162998.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2291_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00428-005-0010-7","volume":"447","author":"I Matos","year":"2005","unstructured":"Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F: p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005, 447: 688-694. 10.1007\/s00428-005-0010-7.","journal-title":"Virchows Arch"},{"key":"2291_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1590\/S1516-31802007000400007","volume":"125","author":"RM Dufloth","year":"2007","unstructured":"Dufloth RM, Matos I, Schmitt F, Zeferino LC: Tissue microarrays for testing basal biomarkers in familial breast cancer cases. Sao Paulo Med J. 2007, 125: 226-230. 10.1590\/S1516-31802007000400007.","journal-title":"Sao Paulo Med J"},{"key":"2291_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-006-0334-y","volume":"450","author":"J Paredes","year":"2007","unstructured":"Paredes J, Lopes N, Milanezi F, Schmitt FC: P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Arch. 2007, 450: 73-80. 10.1007\/s00428-006-0334-y.","journal-title":"Virchows Arch"},{"key":"2291_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/jcp.2007.052431","volume":"61","author":"MA Thorat","year":"2008","unstructured":"Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S: Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. J Clin Pathol. 2008, 61: 327-332. 10.1136\/jcp.2007.052431.","journal-title":"J Clin Pathol"},{"key":"2291_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jcp.2008.059899","volume":"62","author":"S Badve","year":"2009","unstructured":"Badve S, Nakshatri H: Oestrogen receptor-positive breast cancer: towards bridging histopathologic and molecular classifications. J Clin Pathol. 2009, 62: 6-12. 10.1136\/jcp.2008.059899.","journal-title":"J Clin Pathol"},{"key":"2291_CR33","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.ejca.2008.04.020","volume":"44","author":"HO Habashy","year":"2008","unstructured":"Habashy HO, Powe DG, Rakha EA, Ball G, Paish C, Gee J, Nicholson RI, Ellis IO: Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. Eur J Cancer. 2008, 44: 1541-1551. 10.1016\/j.ejca.2008.04.020.","journal-title":"Eur J Cancer"},{"key":"2291_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1055-9965.EPI-06-1090","volume":"17","author":"D Voduc","year":"2008","unstructured":"Voduc D, Cheang M, Nielsen T: GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomarkers Prev. 2008, 17: 365-373. 10.1158\/1055-9965.EPI-06-1090.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2291_CR35","doi-asserted-by":"publisher","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","volume":"96","author":"CM Perou","year":"1999","unstructured":"Perou CM, Jeffrey SS, Rijn van de M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA. 1999, 96: 9212-9217. 10.1073\/pnas.96.16.9212.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2291_CR36","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1038\/sj.onc.1209415","volume":"25","author":"AS Doane","year":"2006","unstructured":"Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, Gerald WL: An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene. 2006, 25: 3994-4008. 10.1038\/sj.onc.1209415.","journal-title":"Oncogene"},{"key":"2291_CR37","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1158\/0008-5472.CAN-07-0746","volume":"67","author":"J Eeckhoute","year":"2007","unstructured":"Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M: Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res. 2007, 67: 6477-6483. 10.1158\/0008-5472.CAN-07-0746.","journal-title":"Cancer Res"},{"key":"2291_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ceb.2008.02.003","volume":"20","author":"H Kouros-Mehr","year":"2008","unstructured":"Kouros-Mehr H, Kim JW, Bechis SK, Werb Z: GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol. 2008, 20: 164-170. 10.1016\/j.ceb.2008.02.003.","journal-title":"Curr Opin Cell Biol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr2327\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:55:18Z","timestamp":1728384918000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,23]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,6]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1186\/bcr2327","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,23]]},"assertion":[{"value":"5 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R40"}}